03/08/2026
TSH and lower T3 both shift things towards insulin resistance. The T4-only therapy may be the cause here. T3 improves insulin markers in rodent experiments.
“Hypothyroidism altered both insulin sensitivity and the levels of selected counter-regulatory hormones. The situation was restored by thyroid hormone replacement, as manifested not only by normalisation of insulin sensitivity, secretion and levels of glucoregulatory hormones, but also by improvement of their relationships.”
“In hypothyroidism... insulin resistance is present mainly at the peripheral tissues."
Mechanisms by which hypothyroidism may cause insulin resistance:
~ Postreceptor insulin-signaling defects in muscle and adipose tissue. Insulin may bind, but the signal is not properly carried into the cell, so the cell responds less to insulin.
~ Decreases in insulin-stimulated glucose transport/phosphorylation. Less glucose is moved into muscle and fat cells and processed after entry, so insulin clears less glucose from the blood.
~ May impair GLUT4 translocation. If GLUT4 does not move well to the cell surface, insulin cannot efficiently drive glucose uptake into cells.
~ Decreases in glycogen synthesis and glycolysis. Cells store less glucose as glycogen and burn less of it, so overall glucose disposal falls.
~ Reduction in insulin-mediated blood flow to muscle and adipose tissue. If insulin cannot raise blood flow well, less glucose is delivered to tissues that should take it up.
~ Decreases in muscle oxidative capacity. Muscle becomes less able to oxidize fuel, which favors inefficient glucose handling and insulin resistance. This causes a whole host of other issues, not least of which is depression.
~ May dysregulate mitochondrial oxidative metabolism via low T3/PGC-1α signaling. Low thyroid signaling may impair mitochondrial function, reducing how well cells use energy and glucose.
~ Reduced intracellular T3 generation in muscle. If muscle makes less local T3, thyroid signaling inside the cell weakens, which may worsen insulin action.
~ May dysregulate leptin action at the hypothalamus. Abnormal leptin signaling may shift whole-body fuel handling in a way that lowers glucose disposal.
~ May involve adipokine-mediated adipocyte-myocyte crosstalk. Signals released from fat may worsen insulin responsiveness in skeletal muscle.
Ref: Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy
Research on subclinical hypothyroidism, which is higher TSH with in-range T4:
TSH causes insulin resistance and increases the chances of type 2 diabetes. Higher TSH within the ‘normal’ range is associated with insulin resistance.
‘Subclinical’ hypothyroidism is when TSH is above the range, but T4 is within range.
Experimental ‘subclinical’ hypothyroidism led to:
~ Decreased glucose infusion rate:
Lower glucose infusion rate means greater insulin resistance (lower insulin sensitivity), because the body needs less infused glucose to maintain the target level (it’s not taking up glucose as effectively under the influence of insulin).
~ Increased free fatty acids:
Seen in type 2 diabetes, obesity, and insulin resistance, these fats interfere with blood glucose levels and the ability to use carbohydrates as fuel efficiently.
~ Higher fasting insulin - indicating insulin resistance.
~ Higher HOMA-IR - more insulin resistance/worse insulin sensitivity.
~ Lower phosphorylated IRS-1-Tyr. This means decreased insulin signaling, leading to higher blood glucose and higher insulin levels.
~ Lower GLUT2, which is needed to handle glucose efficiently.
~ Higher TLR4 and the following downstream molecules ↓
~ p-NF-κB: An inflammatory “switch” that increases cytokines, promoting insulin resistance and contributing to higher blood glucose and higher free fatty acids.
~ p-IRAK-1: This inflammation signal is linked to insulin resistance and can indirectly raise blood glucose and free fatty acids by worsening insulin action.
~ IL-6: Inflammatory cytokine that impairs insulin signaling, increasing insulin resistance, tends to raise blood glucose; can also support higher free fatty acids by reducing insulin’s anti-lipolysis effect in fat.
~ TNF-α: Inflammatory cytokine that directly disrupts insulin signaling and reduces insulin sensitivity; increases insulin resistance, causing higher blood glucose and higher free fatty acids.
“TSH may participate in aggravating inflammation by increasing macrophage infiltration; furthermore, it may activate the TLR4-associated inflammatory signaling pathway, thus interfering with insulin signals in liver tissues. Targeting TSH may have therapeutic benefits against metabolic disorders.” 🐁
The mechanisms help explain why higher TSH (WITHIN the normal range) is associated with insulin resistance in humans.
“It has been reported that overt and mild thyroid dysfunctions are associated with insulin resistance (IR). We performed this retrospective study to evaluate the relationships between thyroid-stimulating hormone (TSH) levels within the reference range and IR...
“RESULTS: TSH levels were positively and linearly associated with HOMA-IR in both the nondiabetic and diabetic groups, as well as in the high- and low-HbA1c groups). A better correlation between TSH levels and HOMA-IR was found in the diabetic group and in the high-HbA1c group when compared with the nondiabetic group and the low-HbA1c group, respectively. Linear regression analysis showed that TSH levels were independently associated with HOMA-IR. CONCLUSIONS Our data suggest that TSH is independently associated with insulin resistance.” 🙍♂️
Ref: Thyroid-stimulating hormone may participate in insulin resistance by activating toll-like receptor 4 in liver tissues of subclinical hypothyroid rats
Thyroid-Stimulating Hormone Levels Are Positively Associated with Insulin Resistance
“T3 treatment decreased glycemia and restored the insulin signaling…” 🐁
“T3… improved insulin sensitivity, and increased insulin synthesis, which may contribute to its anti-diabetic effects.” 🐁
Thyroid hormone improves insulin signaling and reduces the activation of neurodegenerative pathway in the hippocampus of diabetic adult male rats
Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes